XML 62 R96.htm IDEA: XBRL DOCUMENT v2.4.0.6
Supplemental Guarantor Financial Information (Condensed Unaudited Consolidating Statements Of Cash Flows) (Detail) (USD $)
In Thousands, unless otherwise specified
3 Months Ended
Mar. 31, 2013
Mar. 31, 2012
Condensed Financial Statements, Captions [Line Items]    
Net cash provided by (used in) operating activities $ 31,816 $ 43,445
Cash flows (used in) provided by investing activities:    
Cash paid for acquisitions, net, including contingent consideration (9,656) (4,498)
Capital expenditures (25,851) (14,097)
Proceeds from sale of assets 3,411 2,014
Net cash (used in) provided by investing activities (32,096) (16,581)
Cash flows provided by (used in) financing activities:    
Proceeds from issuance of 4.875% senior notes 400,000 0
Repayment of 7.625% senior notes (150,000) 0
Proceeds from credit facility 231,600 166,700
Repayments of credit facility (365,600) (195,950)
Repayments of other borrowings (7,683) (5,323)
(Repayments of) proceeds from book overdrafts (5,970) 10,433
Payments of capital lease obligations (11,438) (4,185)
Proceeds from stock option exercises and other share-based awards 2,838 1,218
Excess tax benefit from stock-based compensation 903 97
Payments for debt extinguishment, call premiums (4,116) 0
Payments of financing costs (6,852) (52)
Net financing activities and advances (to) from consolidated affiliates 0 0
Net cash provided by (used in) financing activities 83,682 (27,062)
Net increase (decrease) in cash and cash equivalents 83,402 (198)
Net effect of currency translation on cash (60) 49
Cash and cash equivalents - beginning of period 26,767 20,280
Cash and cash equivalents - end of period 110,109 20,131
Cash and cash equivalents of discontinued operations 862 4,286
Cash and cash equivalents of continuing operations 109,247 15,845
MasTec, Inc. [Member]
   
Condensed Financial Statements, Captions [Line Items]    
Net cash provided by (used in) operating activities (894) (466)
Cash flows (used in) provided by investing activities:    
Cash paid for acquisitions, net, including contingent consideration 0 0
Capital expenditures 0 0
Proceeds from sale of assets 0 0
Net cash (used in) provided by investing activities 0 0
Cash flows provided by (used in) financing activities:    
Proceeds from issuance of 4.875% senior notes 0  
Repayment of 7.625% senior notes 0  
Proceeds from credit facility 0 0
Repayments of credit facility 0 0
Repayments of other borrowings 0 0
(Repayments of) proceeds from book overdrafts 0 0
Payments of capital lease obligations 0 0
Proceeds from stock option exercises and other share-based awards 2,838 1,218
Excess tax benefit from stock-based compensation 0 0
Payments for debt extinguishment, call premiums 0  
Payments of financing costs 0 0
Net financing activities and advances (to) from consolidated affiliates (1,944) (752)
Net cash provided by (used in) financing activities 894 466
Net increase (decrease) in cash and cash equivalents 0 0
Net effect of currency translation on cash 0 0
Cash and cash equivalents - beginning of period 0 0
Cash and cash equivalents - end of period 0 0
Cash and cash equivalents of discontinued operations 0 0
Cash and cash equivalents of continuing operations 0 0
Guarantor Subsidiaries [Member]
   
Condensed Financial Statements, Captions [Line Items]    
Net cash provided by (used in) operating activities 74,980 63,916
Cash flows (used in) provided by investing activities:    
Cash paid for acquisitions, net, including contingent consideration (9,656) (4,498)
Capital expenditures (25,782) (13,530)
Proceeds from sale of assets 3,340 2,014
Net cash (used in) provided by investing activities (32,098) (16,014)
Cash flows provided by (used in) financing activities:    
Proceeds from issuance of 4.875% senior notes 400,000  
Repayment of 7.625% senior notes (150,000)  
Proceeds from credit facility 231,600 166,700
Repayments of credit facility (365,600) (195,950)
Repayments of other borrowings (7,683) (5,323)
(Repayments of) proceeds from book overdrafts (5,970) 10,433
Payments of capital lease obligations (11,427) (4,177)
Proceeds from stock option exercises and other share-based awards 0 0
Excess tax benefit from stock-based compensation 903 97
Payments for debt extinguishment, call premiums (4,116)  
Payments of financing costs (6,852) (52)
Net financing activities and advances (to) from consolidated affiliates (32,773) (25,371)
Net cash provided by (used in) financing activities 48,082 (53,643)
Net increase (decrease) in cash and cash equivalents 90,964 (5,741)
Net effect of currency translation on cash 0 0
Cash and cash equivalents - beginning of period 17,827 16,240
Cash and cash equivalents - end of period 108,791 10,499
Cash and cash equivalents of discontinued operations 739 4,026
Cash and cash equivalents of continuing operations 108,052 6,473
Non-Guarantor Subsidiaries [Member]
   
Condensed Financial Statements, Captions [Line Items]    
Net cash provided by (used in) operating activities (42,270) (20,005)
Cash flows (used in) provided by investing activities:    
Cash paid for acquisitions, net, including contingent consideration 0 0
Capital expenditures (69) (567)
Proceeds from sale of assets 71 0
Net cash (used in) provided by investing activities 2 (567)
Cash flows provided by (used in) financing activities:    
Proceeds from issuance of 4.875% senior notes 0  
Repayment of 7.625% senior notes 0  
Proceeds from credit facility 0 0
Repayments of credit facility 0 0
Repayments of other borrowings 0 0
(Repayments of) proceeds from book overdrafts 0 0
Payments of capital lease obligations (11) (8)
Proceeds from stock option exercises and other share-based awards 0 0
Excess tax benefit from stock-based compensation 0 0
Payments for debt extinguishment, call premiums 0  
Payments of financing costs 0 0
Net financing activities and advances (to) from consolidated affiliates 34,717 26,123
Net cash provided by (used in) financing activities 34,706 26,115
Net increase (decrease) in cash and cash equivalents (7,562) 5,543
Net effect of currency translation on cash (60) 49
Cash and cash equivalents - beginning of period 8,940 4,040
Cash and cash equivalents - end of period 1,318 9,632
Cash and cash equivalents of discontinued operations 123 260
Cash and cash equivalents of continuing operations 1,195 9,372
Consolidation, Eliminations [Member]
   
Condensed Financial Statements, Captions [Line Items]    
Net cash provided by (used in) operating activities 0 0
Cash flows (used in) provided by investing activities:    
Cash paid for acquisitions, net, including contingent consideration 0 0
Capital expenditures 0 0
Proceeds from sale of assets 0 0
Net cash (used in) provided by investing activities 0 0
Cash flows provided by (used in) financing activities:    
Proceeds from issuance of 4.875% senior notes 0  
Repayment of 7.625% senior notes 0  
Proceeds from credit facility 0 0
Repayments of credit facility 0 0
Repayments of other borrowings 0 0
(Repayments of) proceeds from book overdrafts 0 0
Payments of capital lease obligations 0 0
Proceeds from stock option exercises and other share-based awards 0 0
Excess tax benefit from stock-based compensation 0 0
Payments for debt extinguishment, call premiums 0  
Payments of financing costs 0 0
Net financing activities and advances (to) from consolidated affiliates 0 0
Net cash provided by (used in) financing activities 0 0
Net increase (decrease) in cash and cash equivalents 0 0
Net effect of currency translation on cash 0 0
Cash and cash equivalents - beginning of period 0 0
Cash and cash equivalents - end of period 0 0
Cash and cash equivalents of discontinued operations 0 0
Cash and cash equivalents of continuing operations $ 0 $ 0